Skip to main content
OpenTrials
Completed

NCT Number: NCT04910243

The Practice of Providing Palliative Care in the Situation of the COVID-19 (Coronavirus Disease 2019) Pandemic in Czech Republic

Pandemic of coronavirus SARS-CoV-2 (Severe Acute Respiratory Syndrome coronavirus 2) causing the disease COVID-19 (Coronavirus Disease 2019) overwhelmed healthcare and brought new challenges and stressful situations.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Covid19 COVID-19 Coronaviridae Infections Coronavirus Infections Distress, Emotional Infections Lung Diseases Nidovirales Infections Pneumonia Pneumonia, Viral RNA Virus Infections Respiratory Tract Diseases Respiratory Tract Infections Virus Diseases

Age range

18 year–99 year

Sex eligibility

All sexes

Study type

Observational

Primary location

University Hospital Brno

Brno, 62500, Czechia

About this study

In a short time, the capacities of intensive care units (ICU) were filled in many countries and regions. Due to the need for an excessive number of patients requiring intensive care, physicians and nurses who do not routinely provide care to critically ill patients or do not have the appropriate training (non-ICU clinician) were involved in the care of COVID-19 (Coronavirus Disease 2019) patients. In this context, ICU directly dedicated to the care of patients with COVID-19 ARDS (Acute Respiratory Distress Syndrome) were also opened. Non-ICU clinicians were more or less involved together with the standard ICU staff in palliative care, including End-of-Life decision (EOLD) making, even in a situation of limited scarce resources (equipment or personnel). New workplace and scope of work, which did not correspond to the standard activity or education, most likely led to an increased stress load. EOLD can also be one of the factors leading to increased stress levels. The aim of the project is to describe the practice of palliative care for patients with COVID-19 in a situation of pandemic COVID-19 and to identify factors leading to possible moral distress related with EOLD.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Healthcare providers (physicians and nurses) providing care to patients with COVID-19 admitted at ICU in period of COVID-19 pandemic.

Exclusion criteria

  • Healthcare professionals who did not managed COVID-19 patients admitted at the ICU in situation of COVID-19 pandemic in the period 2020/2021.

Treatment and study plan

questionnaire survey

Other

Physicians providing care to patients with COVID-19 admitted at ICU in period of COVID-19 pandemic will be questioned by electronic web-based survey within Masaryk University information system.

Primary outcomes

  1. Change of practice of providing palliative care at ICU in COVID-19 pandemic

    Time frame: Through study completion, an average of 1 month

    Change of practice of providing palliative care including EOLD practice in patients with COVID-19 admitted at ICU during pandemic.

Secondary outcomes

  1. Risk factors for moral distress

    Time frame: Through study completion, an average of 1 month

    Identify factors leading to moral distress during COVID-19 pandemic and describe possible different risk factors by profession

Sponsors and collaborators

Lead sponsor

Brno University Hospital

Other

Collaborators

  • Masaryk University

Registry information

Official study title

The Practice of Providing Palliative Care in the Situation of the COVID-19 (Coronavirus Disease 2019) Pandemic in the Perspective of Physicians and Nurses - Survey Study

Acronym: PEOpLe-C19

Important dates

Study start
2021
Primary completion
2021
Study completion
2021
First posted
Jun 2, 2021
Registry last updated
Oct 19, 2021

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.